optical coherence tomography- guided photodynamic therapy

31
Optical coherence tomography- guided photodynamic therapy for skin cancer Zaid Hamdoon UCLH Head and Neck Centre

Upload: others

Post on 02-May-2022

8 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Optical coherence tomography- guided photodynamic therapy

Optical coherence tomography-guided photodynamic therapy for

skin cancer

Zaid Hamdoon UCLH Head and Neck

Centre

Page 2: Optical coherence tomography- guided photodynamic therapy

Introduction:

Photodynamic therapy (PDT) has been scientifically used as a novel modality for the treatment of non-melanoma cutaneous malignancies for more than two decades.

This treatment method has an advantage in term of tissue conservation over surgery, which excises esthetical and functionally important tissue

PDT has shown a 75%-100% cure rate for basal cell carcinoma, actinic keratosis, Bowen’s disease, and initial squamous cell carincoma

Page 3: Optical coherence tomography- guided photodynamic therapy

Principles of PDT:

PDT therapy requires the simultaneous presence of light, photosensitizer (PS) and oxygen.

Optimal treatment outcome can not only achieved by these three parameters

Page 4: Optical coherence tomography- guided photodynamic therapy

Tumour margins assessment How accurate is the visual assessment of skin margins? :

Epstein E, Br J Dermatol. 1973 Jul;89(1):37-43. More than 30% error in the assessment.

High resolution Ultrasound

1-poor resolution to define early cancer . 2-poor contrast.

Page 5: Optical coherence tomography- guided photodynamic therapy

Fluorescence-guided surgery

Bramdt et al. J Otolaryngol. 2007 Jun;36(3):148-55

Page 6: Optical coherence tomography- guided photodynamic therapy

Wang et al. J Biophotonics. 2011 May;4(5):335-44.

Forsea et al. J Med Life. 2010 Oct-Dec;3(4):381-9.

Khandwala et al. Br J Ophthalmol. 2010 Oct;94(10):1332-6.

Mogensen et al. Semin Cutan Med Surg. 2009 Sep;28(3):196-202.

Page 7: Optical coherence tomography- guided photodynamic therapy

No-melanoma skin cancer study. This open, non-comparative case series study   Ethical approval acquired   Informed consent   Exclusion criteria included: 1-previous, surgery, cryotherapy used within 2 months of the study. 2-history of photodermatoses.

3-pregnancy or lactation.

  Carried out at UCLH   12 patients with consecutive 18 skin lesions

Page 8: Optical coherence tomography- guided photodynamic therapy

Demographics

  Age 37-78  Gender: 5 (42%) M; 7 (58%) F   Clinical features: papule 5(42%), Nodule 4(33%), ulcer 3

(25%)

  Site: Cheek 4 (22%), Forehead 4 (22%), Nose 4 (22%), Nasolabial fold 2(11%) , Lower eyelid 1(5.5%) , Lower lip 1(5.5%) , Upper lip 1(5.5%)

  Fitzpatrick skin types: Type II 3(25%), Type III 4(33%), Type IV 5(42%)

Page 9: Optical coherence tomography- guided photodynamic therapy

Aims of study

•  to demonstrate the technical feasibility of OCT to map real tumor margins

•  to monitor skin changes that occurred after PDT

•  Final clinical and aesthetic outcome

Page 10: Optical coherence tomography- guided photodynamic therapy

  Foscan (mTHPC) 0.05 mg/kg, was slowly administered intravenously into an antecubital vein.

  48 h later laser illumination of the lesion surface by 200 J/cm2 red light 630 ± 15 nm. Anesthesia may or not need.

  patients were advised to avoid bright ambient light for 4 weeks.

Study setting

Page 11: Optical coherence tomography- guided photodynamic therapy

Conventional way

Page 12: Optical coherence tomography- guided photodynamic therapy

In-vivo Optical coherence tomography image guiding

Page 13: Optical coherence tomography- guided photodynamic therapy

Outcome measures Results 1, 3, 6 and 12 months after last treatment were obtained.

The primary outcomes were the clinical lesion response at 6 months 1-CR: complete clearance of the lesion 2-Non-CR: (non-complete clearance of the lesion) 3-partial response (PR).

The secondary outcomes were as follows: lesion recurrence at

12 months.

The cosmetic outcome assessed by the investigator at 12 months on a 4-point scale.

(0: poor, 1: fair, 2: good, 3: excellent).

Page 14: Optical coherence tomography- guided photodynamic therapy

Morphometric and architectural features of OCT images obtained before and after PDT

Our previous study on skin cancer set diagnostic Criteria :

Baseline Evaluation of the OCT images

Normal

Page 15: Optical coherence tomography- guided photodynamic therapy

Transition from the normal area toward diseased area

Page 16: Optical coherence tomography- guided photodynamic therapy

Early stage AC with strong signal reflection at the stratum corneum layer which is already separated from the epidermis.

Page 17: Optical coherence tomography- guided photodynamic therapy

Advanced squamous cell carcinoma of check with area of transition from normal toward thickened epidermis with dermis invasive. The area of advance invasion show hypoechoic feature as a sign of tumor cells necrosis

Page 18: Optical coherence tomography- guided photodynamic therapy

Single nodular basal cell carcinoma lesion showing a single hyporeintensive tumour nest

Multinodular basal cell carcinoma presenting as multiple, closely arranged, distinct cancer lobule

Page 19: Optical coherence tomography- guided photodynamic therapy

Mixed cystic and nodular basal cell carcinoma lesion showing two distinctive hyporeflective areas.

Page 20: Optical coherence tomography- guided photodynamic therapy

Baseline

1 month

Six month

AK

Page 21: Optical coherence tomography- guided photodynamic therapy

Baseline 1 month

3 months 12 months

SCC

Page 22: Optical coherence tomography- guided photodynamic therapy

Baseline

1 month

Six month

Nodular BCC

Page 23: Optical coherence tomography- guided photodynamic therapy

Final outcome

Baseline 12 months

Primary out come: complete clearance of the lesion Secondary outcome: no recurrence Aesthetic outcome: excellent

Page 24: Optical coherence tomography- guided photodynamic therapy

Baseline 12 months

Primary out come: complete clearance of the lesion Secondary outcome: no recurrence Aesthetic outcome: good

Page 25: Optical coherence tomography- guided photodynamic therapy

Primary out come: complete clearance of the lesion Secondary outcome: no recurrence Aesthetic outcome: fair

Baseline 12 months

Page 26: Optical coherence tomography- guided photodynamic therapy

Primary out come: partial clearance of the lesion Aesthetic outcome: fair

Baseline 12 months

Page 27: Optical coherence tomography- guided photodynamic therapy

Cosmetic camouflaging

Page 28: Optical coherence tomography- guided photodynamic therapy

Clinical response

Clinical CR in full list time was observed in seventeen (94.5%) lesions and PR in one (5.5%), the total response rate was 100%. Among there were 17 cases of CR, 10 cases completely disappeared after the third month, 5 after the sixth, 3 after 12 months.

For 1 PR case, even though the tumours did not disappear completely, their margins cleared distinctly (100%) at the end of pdt.

Cosmesis

Page 29: Optical coherence tomography- guided photodynamic therapy

Conclusion 1-This study demonstrates the feasibility of OCT to detect, monitor, and quantify changes after PDT.

2-OCT imaging system provided a unique opportunity to assess the effects of PDT on normal skin

3-OCT does indeed aid in the planning of PDT

4-OCT-guided PDT has been shown to be an inexpensive and valuable guide in the treatment of nonmelanotic

cutaneous malignancies

Page 30: Optical coherence tomography- guided photodynamic therapy

Acknowledgement

•  Colin Hopper •  Waseem Jerjes •  Tahwinder Upile UCLH Head and Neck Centre

Gordon McKenzie: Michelson's Diagnostics

Page 31: Optical coherence tomography- guided photodynamic therapy

Thank you